Q96-30270-30167 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-23
Dose 1 — Pfizer-BioNTech
2021-03-24
Registered in v-safe
2021-03-24
Survey response — days 1–6 daily, dose 1
MedDRA: Odynophagia — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal pain · Be unable to do your normal daily activities

Free text: Soreness when swallowing

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-25
Survey response — days 1–6 daily, dose 1
MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activities

Free text: Swollen inguinal lymph node

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-26
Survey response — days 1–6 daily, dose 1
MedDRA: Lymphadenopathy — Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activities

Free text: Swollen lymph nodes

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-27
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Muscle or body aches, Fatigue or tiredness, Diarrhea

Adult check-in
2021-03-29
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Headache, Diarrhea · Be unable to do your normal daily activities

Adult check-in
2021-04-17
Dose 2 — Pfizer-BioNTech
2021-04-18
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-04-19
Survey response — days 1–6 daily, dose 2
MedDRA: Condition aggravated, Office visit, Pre-existing disease — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal pain · Be unable to work, Be unable to do your normal daily activities

Free text: Episcleritis flare up; went to eye doctor today for it.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-21
Survey response — days 1–6 daily, dose 2
MedDRA: Condition aggravated, Episcleritis, Office visit, Pre-existing disease — Feeling: Fair · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional

Free text: Systemic reaction (other): Episcleritis flare up · Healthcare visit (other): Eye doctor for episcleritis flare up

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-21
Report sent to call center — days 1–6 daily, dose 2
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2022-04-02
Call successful
Participant prefers to complete VAERS report online
2022-04-17
Survey response — 12 months, dose 2
MedDRA: Abortion spontaneous — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit

Free text: Two miscarriages after first and second dose

MedDRA releases: 2024-11 · check-in free text available
2022-04-17
Report sent to call center — 12 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
2022-04-19
Call successful
Participant prefers to complete VAERS report online

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-23	Pfizer-BioNTech
2	2021-04-17	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2021-04-21	Successful 2022-04-02	Participant prefers to complete VAERS report online
2022-04-17	Successful 2022-04-19	Participant prefers to complete VAERS report online

Free text

Release 6 — days 1–6 daily, dose 1

2021-03-24

Systemic reaction (other): Soreness when swallowing

2021-03-25

Systemic reaction (other): Swollen inguinal lymph node

2021-03-26

Systemic reaction (other): Swollen lymph nodes

Release 7 — days 1–6 daily, dose 2

2021-04-19

Systemic reaction (other): Episcleritis flare up; went to eye doctor today for it.

2021-04-21

Systemic reaction (other): Episcleritis flare up

Healthcare visit (other): Eye doctor for episcleritis flare up

Release 11 — 12 months, dose 2

2022-04-17

Symptoms: Two miscarriages after first and second dose

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
HCVO	Condition aggravated	·	·	✓
HCVO	Office visit	✓	✓	✓
HCVO	Pre-existing disease	·	·	✓
SD	Abortion spontaneous	·	·	✓
SRO	Condition aggravated	✓	✓	✓
SRO	Episcleritis	✓	✓	○
SRO	Lymphadenopathy	✓	✓	✓
SRO	Odynophagia	✓	✓	✓
SRO	Office visit	✓	✓	✓
SRO	Pre-existing disease	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release